arrow
R

Reinhard W. Holl

caqm
H指数:93
被引数:3.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

GLP-1 receptor agonists or SGLT2-inhibitors? Evaluation of a personalized treatment algorithm for individuals with type 2 diabetes: a registry-based cohort study

GLP-1受体激动剂或SGLT2抑制剂?针对2型糖尿病患者的个性化治疗算法评估:一项基于注册登记的队列研究

2026-03-010
PRE
Comparison of demographics and treatment outcome in children with type 1 diabetes related to the economic background of their country of residence: observations from the SWEET database

比较儿童1型糖尿病的基线人口特征与治疗结局,及其与居住国经济背景的关系:来自SWEET数据库的观察结果

2025-12-220
PRE
A cohort description and comparison of four European national diabetes registries for the REDDIE project

四个欧洲国家糖尿病登记研究的队列描述与比较(REDDIE项目)

2025-10-010
OAAI
Spatiotemporal associations between incidence of type 1 diabetes and COVID-19 vaccination rates in children in Germany - a population-based ecological study

德国儿童中1型糖尿病发病率与COVID-19疫苗接种率的空间时间关联性研究——一项基于人群的生态学研究

2025-09-010
OA
Prospective associations between coping, benefit-finding and growth, and subjective well-being in youths with chronic health conditions: a two-wave cross-lagged analysis

应对、获益发现与成长与慢性健康状况青少年主观幸福感之间的前瞻性关联:一项两波交叉滞后分析

2025-09-011
OAAI
Heterogeneity in response to GLP-1 receptor agonists in type 2 diabetes in real-world clinical practice: insights from the DPV register - an IMI-SOPHIA study

2型糖尿病对GLP-1受体激动剂反应的异质性:来自DPV登记册的见解 - 一项IMI-SOPHIA研究

2025-05-220
OA
Effectiveness of add-on therapy with SGLT2 inhibitors or GLP-1 receptor agonists in adults with type 1 diabetes: A prospective DPV registry study

SGLT2抑制剂或GLP-1受体激动剂添加治疗成人1型糖尿病的有效性: 一项前瞻性DPV注册研究

2024-12-270
PRE
What is the Relationship Between Time in Range, Time in Tight Range, and HbA1c in Youth and Young Adults With Type 1 Diabetes? Results From the German/Austrian/Luxembourgian/Swiss Diabetes Prospective Follow-Up Registry

青年和青年1型糖尿病患者的HbA1c与范围内时间,紧密范围内时间之间的关系是什么?德国/奥地利/卢森堡/瑞士糖尿病前瞻性随访登记结果

2024-11-160
PRE
Increased cardiovascular risk in people with LADA in comparison to type 1 diabetes and type 2 diabetes: Findings from the DPV registry in Germany and Austria

与1型糖尿病和2型糖尿病相比,LADA患者的心血管风险增加: 来自德国和奥地利DPV注册中心的发现

2024-11-110
OAAI